Literature DB >> 7746750

Treatment of acquired muscle spasticity using phenol peripheral nerve blocks.

M J Botte1, R A Abrams, S C Bodine-Fowler.   

Abstract

The use of phenol motor nerve blocks is advantageous in the early period of acquired spasticity (ie, that occurring following traumatic brain injury or incomplete spinal cord injury), when increased muscle tone is often the most severe. Because acquired spasticity is dynamic and usually improves slowly, a temporary treatment method used to ameliorate increased muscle tone is desirable. Phenol nerve infiltration provides a temporary motor nerve block that lasts for weeks or months. It allows passive limb mobilization in a comprehensive rehabilitation program that attempts to prevent fixed soft tissue contractures. Permanent or irreversible methods such as operative tendon lengthening, muscle release or recession, or neurectomy are usually best delayed until the spasticity has become static, when the need for surgical correction becomes more firmly indicated, and outcomes of operative intervention are more predictable. Although phenol nerve blocks were initially administered at the spinal cord level to control spasticity, the potential side effects have caused a loss of popularity of this method of administration. The safer and more common use of phenol infiltration at the peripheral nerve level is now more accepted for brain injury and spinal cord injury patients. This report reviews the indications, current concepts, and development of the different methods used to administer phenol nerve blocks. Comparisons to other methods to control spasticity are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746750     DOI: 10.3928/0147-7447-19950201-14

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  5 in total

Review 1.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

2.  Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.

Authors:  T Ubhi; B B Bhakta; H L Ives; V Allgar; S H Roussounis
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

3.  Phenol reduces hypertonia and enhances strength: a longitudinal case study.

Authors:  Patrick H McCrea; Janice J Eng; Rhonda Willms
Journal:  Neurorehabil Neural Repair       Date:  2004-06       Impact factor: 3.919

4.  Spasticity.

Authors:  Allison Brashear; Kelly Lambeth
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

5.  Percutaneous chemical nerve block with ultrasound-guided intraneural injection.

Authors:  Jongmin Lee; Yang Soo Lee
Journal:  Eur Radiol       Date:  2008-03-21       Impact factor: 7.034

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.